Future Market Insights (FMI), a renowned market intelligence and consulting firm, unveils an exclusive analysis, projecting a substantial surge in the Global Interventional Radiology Industry. According to FMI’s forecast, the industry is poised to elevate from US$ 24.9 Billion in 2021 to an impressive US$ 42.7 Billion market by 2032, exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 5% during the forecast period.
The unprecedented growth in the Global Interventional Radiology Industry is attributed to the escalating demand for advanced treatment methods, leveraging cutting-edge scanners and X-ray vision technology. This surge is primarily driven by the increasing prevalence of chronic diseases on a global scale, necessitating more efficient and precise diagnostic and treatment approaches.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14344
The necessary impetus for the rapid growth of interventional radiology, which is visible in emerging nations as well, has been provided by the introduction of interventional radiology in all levels of healthcare facilities. As the non-emergency medical services were abruptly halted during the outbreak of Covid-19 Mandeville in 2020 it had some negative impacts on the growing demand for interventional radiology devices installations.
However, the later discovery of seriousness associated with co-morbid diseases the Global Interventional Radiology Industry surged with rising introduction of interventional radiology in new healthcare and medical facilities. In the post-pandemic years the application of radiology equipment has grown favouring the interventional radiology service providers. Several devices equipped with modern technologies such as X-ray systems, MRI Scanners, CT Scanners and other type of medical imaging equipment have dominated the healthcare sector in recent days.
Key Takeaways
- By 20221, Cardiology Segment was valued at US$ 7.7 Bn in terms of revenue contributed to the Global Interventional Radiology Industry
- The Gastroenterology segment is poised to record a higher growth projection during the forecast years reaching a value of more than US $ 2 Bn by 2028.
- Among several procedures, the angioplasty segment will be expected to grow at a CAGR of 5.8% during the forecast period.
- The US market dominates the interventional radiology for medical students having a net worth of more than US$ 8 Bn.
- In Europe, Germany is the prominent region for the interventional radiology market players valued at US$ 1.5 Bn in terms of revenue generated.
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14344
Competitive Landscape
Carestream Health Inc., Hologic Inc., GE Healthcare, Fujifilm Corporation, Samsung Healthcare (Samsung Electronics Co., Ltd.), Shimadzu Corporation, Siemens Healthineers, Canon Medical Systems Corporation, and Olympus Corporation are some of the prominent players in the Global Interventional Radiology Industry covered by the market analysis report.
A large number of local players have occupied the market by supplying equipment related to interventional radiology for medical student’s requirements.
- In the field of ultrasound, digital radiography and computed tomography Samsung Healthcare, a subsidiary of Samsung Electronics Co., Ltd, launched a premium product for diagnostic imaging solutions in December 2020. This initiative for ultrasound-guided interventional procedures carried out at the Radiology Society of North America (RSNA) 2020 assisted the company in expanding its product portfolio in North America and beyond.
- Canon Medical launched an upgraded product under the Aquilion ONE/PRISM Edition by the name of One-Beat Spectral Cardiac CT in November 2020. THE Aquillion Edition assisted with deep learning spectral capabilities is a major development in the field of cardiac exams and after interventional radiology glasses.
- GE Healthcare division of General Electrical Company launched an advanced ultrasound system by the name of LOGIQ E10 in March 2018. This system has been equipped with comprehensive tools that can provide treatment for a wide range of diseases and remote control applications to improve efficiency.
Key Segments
By Product:
- MRI Systems
- CT Scanners
- Ultrasound Imaging Systems
- Angiography Systems
- Others
By Procedure:
- Angioplasty
- Biopsy
- Embolization
- Peripheral Embolization
- Prostatic Artery Embolization
- Genicular Artery Embolization
- Fibroid
- Others
- Thrombolysis
- Vertebroplasty
- Nephrostomy
- Interventional Oncology
- MSK Intervention
- Others
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/14344
By Application:
- Cardiology
- Oncology
- Urology
- Gastroenterology
- Obstetrics
- Gynaecology
- Others
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube